| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |